TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate-0.17-0.18-0.69-0.31
Low Estimate-0.21-0.21-0.78-0.53
High Estimate-0.14-0.15-0.550.03
Year Ago EPS-0.15-0.16-0.59-0.69
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate5.12M7.9M30.12M158.28M
Low Estimate4.73M6.9M25.87M85.18M
High Estimate5.5M8.57M33.07M257.33M
Year Ago Sales3.76MN/A16.1M30.12M
Sales Growth (year/est)36.10%N/A87.10%425.50%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.12-0.21-0.17-0.17
EPS Actual-0.15-0.16-0.17-0.16
Difference-0.030.0500.01
Surprise %-25.00%23.80%0.00%5.90%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.17-0.18-0.69-0.31
7 Days Ago-0.17-0.18-0.69-0.31
30 Days Ago-0.17-0.18-0.69-0.25
60 Days Ago-0.17-0.18-0.69-0.25
90 Days Ago-0.16-0.16-0.65-0.08
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/A1
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-13.30%N/AN/A0.00
Next Qtr.-12.50%N/AN/A0.03
Current Year-16.90%N/AN/A0.04
Next Year55.10%N/AN/A0.10
Next 5 Years (per annum)19.50%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A